文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

在 SARS-CoV-2 持续阳性逆转录聚合酶链反应结果的病例中推断病毒的活跃复制。

Inference of Active Viral Replication in Cases with Sustained Positive Reverse Transcription-PCR Results for SARS-CoV-2.

机构信息

Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain.

出版信息

J Clin Microbiol. 2021 Jan 21;59(2). doi: 10.1128/JCM.02277-20.


DOI:10.1128/JCM.02277-20
PMID:33239378
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8111132/
Abstract

The purpose of this study was to detect coronavirus disease 2019 (COVID-19) cases with persistent positive reverse transcription-PCR (RT-PCR) results for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), for which viable virus can be inferred due to the presence of subgenomic (SG) viral RNA, which is expressed only in replicating viruses. RNA remnants purified from diagnostic nasopharyngeal specimens were used as the templates for RT-PCR-specific detection of SG E gene RNA. As controls, we also detected viral genomic RNA for the E gene and/or a human housekeeping gene (RNase P). We assessed the samples of 60 RT-PCR-positive cases with prolonged viral SARS-CoV-2 shedding (24 to 101 days) since the first diagnostic RT-PCR. SG viral RNA was detected in 12/60 (20%) of the persistent cases, 28 to 79 days after the onset of symptoms. The age range of the cases with prolonged viral shedding and the presence of SG RNA was quite wide (40 to 100 years), and the cases were equally distributed between males (42%) and females (58%). No case was HIV positive, although seven were immunosuppressed. According to the severities of the COVID-19 episodes, they were mild (40%), intermediate (20%), and severe (40%). In a percentage of persistent SARS-CoV-2 PCR-positive cases, the presence of actively replicating virus may be inferred, far beyond diagnosis. We should not assume a universal lack of infectiousness for COVID-19 cases with prolonged viral shedding.

摘要

本研究旨在检测持续出现新型冠状病毒(SARS-CoV-2)阳性逆转录-聚合酶链反应(RT-PCR)结果的 2019 年冠状病毒病(COVID-19)病例,因为存在亚基因组(SG)病毒 RNA,可推断出有存活病毒,因为只有复制病毒才能表达亚基因组 RNA。将从诊断性鼻咽标本中纯化的 RNA 残留物用作 RT-PCR 特异性检测 SG E 基因 RNA 的模板。作为对照,我们还检测了用于 E 基因和/或人类管家基因(RNase P)的病毒基因组 RNA。我们评估了 60 例延长病毒 SARS-CoV-2 脱落(24 至 101 天)的持续阳性 RT-PCR 病例的样本。在症状出现后 28 至 79 天,12/60(20%)的持续病例中检测到 SG 病毒 RNA。具有延长病毒脱落和 SG RNA 的病例的年龄范围相当广泛(40 至 100 岁),并且男性(42%)和女性(58%)之间的病例分布均匀。尽管有 7 例免疫抑制,但没有 HIV 阳性病例。根据 COVID-19 发作的严重程度,它们为轻度(40%)、中度(20%)和重度(40%)。在持续的 SARS-CoV-2 PCR 阳性病例中,存在活跃复制的病毒可能被推断,远远超出了诊断范围。我们不应该假设具有延长病毒脱落的 COVID-19 病例普遍缺乏传染性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ef3/8111132/2a33cdc946c0/JCM.02277-20-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ef3/8111132/2a33cdc946c0/JCM.02277-20-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ef3/8111132/2a33cdc946c0/JCM.02277-20-f0001.jpg

相似文献

[1]
Inference of Active Viral Replication in Cases with Sustained Positive Reverse Transcription-PCR Results for SARS-CoV-2.

J Clin Microbiol. 2021-1-21

[2]
Persistent SARS-CoV-2 RNA Shedding Without Evidence of Infectiousness: A Cohort Study of Individuals With COVID-19.

J Infect Dis. 2021-10-28

[3]
Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Tropism in the Lungs, Airways, and Vascular Endothelium of Patients With Fatal Coronavirus Disease 2019: An Autopsy Case Series.

J Infect Dis. 2021-3-3

[4]
Quantitative detection of SARS-CoV-2 RNA in nasopharyngeal samples from infected patients with mild disease.

J Med Virol. 2021-4

[5]
Prolonged SARS-CoV-2 Positivity in Immunocompetent Patients: Virus Isolation, Genomic Integrity, and Transmission Risk.

Microbiol Spectr. 2021-12-22

[6]
[Evaluation of Viral Subgenomic RNAs and Antigen Presence in SARS-CoV-2 PCR Positive Cases].

Mikrobiyol Bul. 2024-7

[7]
Shedding of Viable Virus in Asymptomatic SARS-CoV-2 Carriers.

mSphere. 2021-5-19

[8]
Persistence of SARS-CoV-2 RNA in the nasopharyngeal, blood, urine, and stool samples of patients with COVID-19: a hospital-based longitudinal study.

Virol J. 2021-7-1

[9]
Detection of SARS-CoV-2 in conjunctival secretions from patients without ocular symptoms.

Infection. 2021-4

[10]
Clinical characteristics and potential factors for recurrence of positive SARS-CoV-2 RNA in convalescent patients: a retrospective cohort study.

Clin Exp Med. 2021-8

引用本文的文献

[1]
The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management.

J Thromb Thrombolysis. 2025-1

[2]
Predicting the presence of infectious virus from PCR data: A meta-analysis of SARS-CoV-2 in non-human primates.

PLoS Pathog. 2024-4

[3]
Nirmatrelvir and ritonavir combination against COVID-19 caused by omicron BA.2.2 in the elderly: A single-center large observational study.

Immun Inflamm Dis. 2024-4

[4]
When to test for COVID-19 using real-time reverse transcriptase polymerase chain reaction: a systematic review.

Int J Infect Dis. 2022-10

[5]
Comparison of pneumonia features in children caused by SARS-CoV-2 and other viral respiratory pathogens.

Pediatr Pulmonol. 2022-10

[6]
Rapid and Specific Detection of Active SARS-CoV-2 With CRISPR/Cas12a.

Front Microbiol. 2022-1-28

[7]
Controlling long-term SARS-CoV-2 infections can slow viral evolution and reduce the risk of treatment failure.

Sci Rep. 2021-11-19

[8]
Feasibility and Effectiveness Assessment of SARS-CoV-2 Antigenic Tests in Mass Screening of a Pediatric Population and Correlation with the Kinetics of Viral Loads.

Viruses. 2021-10-14

[9]
SARS-CoV-2 Subgenomic RNAs: Characterization, Utility, and Perspectives.

Viruses. 2021-9-24

[10]
Viral Culture Confirmed SARS-CoV-2 Subgenomic RNA Value as a Good Surrogate Marker of Infectivity.

J Clin Microbiol. 2022-1-19

本文引用的文献

[1]
SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease.

Emerg Infect Dis. 2020-8-4

[2]
Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19.

J Med Virol. 2021-1

[3]
Investigating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Surface and Air Contamination in an Acute Healthcare Setting During the Peak of the Coronavirus Disease 2019 (COVID-19) Pandemic in London.

Clin Infect Dis. 2021-10-5

[4]
Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples.

Clin Infect Dis. 2020-12-17

[5]
Prolonged Persistence of SARS-CoV-2 RNA in Body Fluids.

Emerg Infect Dis. 2020-5-8

[6]
Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards.

Eur J Clin Microbiol Infect Dis. 2020-4-27

[7]
The Architecture of SARS-CoV-2 Transcriptome.

Cell. 2020-4-23

[8]
Temporal dynamics in viral shedding and transmissibility of COVID-19.

Nat Med. 2020-4-15

[9]
Virological assessment of hospitalized patients with COVID-2019.

Nature. 2020-4-1

[10]
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Lancet. 2020-3-11

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索